TuHURA Biosciences, Inc.
HURA · NASDAQ
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $14 | $5 | $4 | $0 |
| G&A Expenses | $0 | $5 | $0 | $2 |
| SG&A Expenses | $9 | $5 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $24 | $10 | $6 | $2 |
| Operating Income | $0 | -$10 | -$6 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | $0 | -$10 | -$6 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23 | -$10 | -$6 | -$0 |
| % Margin | – | – | – | – |
| EPS | 0 | -0.214 | -0.142 | -3 |
| % Growth | 100% | -50.9% | 95.3% | – |
| EPS Diluted | 0 | -0.214 | -0.142 | -3 |
| Weighted Avg Shares Out | 0 | 45 | 42 | 2 |
| Weighted Avg Shares Out Dil | 0 | 45 | 42 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$10 | -$5 | -$2 |
| % Margin | – | – | – | – |